Medicare Enrolled
Dr. Sanaullah Khalid, M.D.
Hematology & Oncology · Youngstown, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khalid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khalid?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khalid
Dr. Sanaullah Khalid is a hematology & oncology specialist in Youngstown, OH, with 15 years of NPI registration. Based on federal Medicare data, Dr. Khalid performed 163,514 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khalid received a total of $216,263 from 81 pharmaceutical and/or device companies across 775 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khalid is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 1% volume in OH
$216,263 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗163,514
Medicare services
Top 1% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
55,590 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 36,205 | $40 | $126 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
24,750 | $1 | $4 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
14,800 | $2 | $20 |
| Denosumab injection (Prolia/Xgeva) | 11,221 | $18 | $55 |
| Anti-nausea injection (aprepitant) | 8,450 | $1 | $8 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,618 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 2,490 | $0 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
833 | $61 | $152 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
716 | $91 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
681 | $21 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
418 | $10 | $96 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
410 | $11 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $89 | $231 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
281 | $51 | $211 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
242 | $43 | $313 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
193 | $2 | $19 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
166 | $129 | $310 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
162 | $89 | $239 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
153 | $46 | $344 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
126 | $14 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
121 | $20 | $161 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
115 | $1 | $7 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
112 | $1 | $17 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
111 | $9 | $75 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
89 | $39 | $289 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
87 | $22 | $256 |
| New patient office visit, complex (60-74 min) | 62 | $156 | $445 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
56 | $17 | $114 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 56 | $336 | $1,722 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $59 | $162 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $130 | $424 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $17 | $72 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
50.5% high complexity
48.4% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$216,263
Total received (2018-2024)
Avg $30,895/year across 7 years
Top 5% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
775
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57,871
2023
$62,157
2022
$23,179
2021
$11,992
2020
$15,077
2019
$43,039
2018
$2,949
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$33,951
JAZZ PHARMACEUTICALS INC.
$18,744
Sirtex Medical Inc
$2,695
Novartis Pharmaceuticals Corporation
$305
PFIZER INC.
$303
ABBVIE INC.
$239
GENZYME CORPORATION
$150
Takeda Pharmaceuticals U.S.A., Inc.
$150
AstraZeneca Pharmaceuticals LP
$140
Merck Sharp & Dohme LLC
$98
Janssen Biotech, Inc.
$78
Exelixis Inc.
$77
GlaxoSmithKline, LLC.
$71
Acrotech Biopharma Inc.
$71
Genmab U.S., Inc.
$69
Celgene Corporation
$65
Incyte Corporation
$60
Daiichi Sankyo Inc.
$58
Lilly USA, LLC
$56
Eisai Inc.
$55
BeiGene USA, Inc.
$53
Gilead Sciences, Inc.
$37
Rigel Pharmaceuticals, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$33
Ipsen Biopharmaceuticals, Inc
$31
ARRAY BIOPHARMA INC
$31
Astellas Pharma US Inc
$25
Sumitomo Pharma America, Inc.
$24
Tolmar, Inc.
$22
ADC Therapeutics America, Inc.
$20
Tempus AI, Inc
$19
Mirati Therapeutics, Inc.
$19
Pharmacosmos Therapeutics Inc.
$19
Blueprint Medicines Corporation
$18
Regeneron Healthcare Solutions, Inc.
$17
Aadi Bioscience, Inc.
$17
Kyowa Kirin, Inc.
$16
Top 3 companies account for 95.7% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$155,033
JAZZ PHARMACEUTICALS INC.
$18,767
Merck Sharp & Dohme Corporation
$9,241
Verastem, Inc.
$7,920
GlaxoSmithKline, LLC.
$7,522
AstraZeneca Pharmaceuticals LP
$3,794
Sirtex Medical Inc
$2,695
Novartis Pharmaceuticals Corporation
$1,118
Celgene Corporation
$1,074
EMD Serono, Inc.
$708
PFIZER INC.
$649
Takeda Pharmaceuticals U.S.A., Inc.
$588
BeiGene USA, Inc.
$578
Incyte Corporation
$494
Amgen Inc.
$390
GENZYME CORPORATION
$346
Pharmacyclics LLC, An AbbVie Company
$346
Janssen Biotech, Inc.
$337
Genentech USA, Inc.
$323
Astellas Pharma US Inc
$277
Lilly USA, LLC
$244
Exelixis Inc.
$243
ABBVIE INC.
$239
Merck Sharp & Dohme LLC
$230
Eisai Inc.
$181
ASD SPECIALTY HEALTHCARE, LLC
$166
Ipsen Biopharmaceuticals, Inc
$164
Bayer HealthCare Pharmaceuticals Inc.
$161
Daiichi Sankyo Inc.
$156
ASD Specialty Healthcare, LLC
$124
Acrotech Biopharma Inc.
$110
ARRAY BIOPHARMA INC
$107
Seagen Inc.
$107
Myovant Sciences Inc.
$92
Genmab U.S., Inc.
$90
Kyowa Kirin, Inc.
$89
Alexion Pharmaceuticals, Inc.
$86
Sumitomo Pharma America, Inc.
$78
Blueprint Medicines Corporation
$77
Gilead Sciences, Inc.
$76
Bayer Healthcare Pharmaceuticals Inc.
$65
Rigel Pharmaceuticals, Inc.
$65
Regeneron Healthcare Solutions, Inc.
$61
Heron Therapeutics, Inc.
$61
TESARO, Inc.
$58
Acrotech Biopharma LLC
$56
Karyopharm Therapeutics Inc.
$56
Pharmacyclics LLC, an AbbVie Company
$48
AVEO Pharmaceuticals, Inc.
$44
TOLMAR Pharmaceuticals, Inc.
$44
ADC Therapeutics America, Inc.
$41
Emmaus Medical, Inc.
$40
Tolmar, Inc.
$38
EISAI INC.
$34
Pharmacosmos Therapeutics Inc.
$33
MorphoSys, US Inc.
$33
Dova Pharmaceuticals
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
TAIHO ONCOLOGY, INC.
$29
MEDIVATION FIELD SOLUTIONS LLC
$23
AbbVie, Inc.
$22
Myriad Genetic Laboratories, Inc.
$22
SOBI, INC
$22
Apellis Pharmaceuticals, Inc.
$19
Tempus AI, Inc
$19
Mirati Therapeutics, Inc.
$19
Stemline Therapeutics Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Jazz Pharmaceuticals Inc.
$18
Sobi, Inc
$18
Secura Bio, Inc.
$17
Aurobindo Pharma USA, Inc.
$17
Aadi Bioscience, Inc.
$17
G1 Therapeutics, Inc.
$16
Amneal Pharmaceuticals LLC
$16
Adaptive Biotechnologies Corporation
$15
Puma Biotechnology, Inc.
$13
Lexicon Pharmaceuticals, Inc.
$13
Dendreon Pharmaceuticals LLC
$12
Seattle Genetics, Inc.
$11
Shionogi Inc
$11
Top 3 companies account for 84.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fyarro · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Mulpleta · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Tepmetko · Tivdak · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vectibix · Venclexta · Vitrakvi · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
22
County median income
$55,576
Nearest hospital to ZIP centroid (approximate)
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khalid is a mixed practice specialist, with above-average Medicare volume (top 1% in OH), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khalid experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Khalid performed 55,590 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khalid receive payments from pharmaceutical companies?
Yes. Dr. Khalid received a total of $216,263 from 81 companies across 775 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khalid's costs compare to other hematology & oncology specialists in Youngstown?
Dr. Khalid's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khalid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Youngstown
Browse hematology & oncology specialists in Youngstown ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology